Multiple Mechanisms are Involved in the Acute Vasodilatory Effect of 17β-Estradiol in the Isolated Perfused Rat Heart
- 1 June 1999
- journal article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 33 (6) , 852-858
- https://doi.org/10.1097/00005344-199906000-00004
Abstract
The purpose of this study was to define the dose-dependent effects of 17β-estradiol on coronary flow and cardiac function in isolated rat hearts and to identify the mechanisms involved in its vasodilator action. Hearts from female and male Wistar rats were perfused at constant pressure (100 mm Hg). Stereoisomer specificity and the mechanism of vasodilation by 17β-estradiol were examined in female rat hearts. Function was measured by a left ventricular (LV) balloon and coronary flow (CF) with an ultrasonic flowmeter. 17β-Estradiol at 10−6, 5 × 10−6, and 10−5M increased CF in female hearts by 5 ± 2, 27 ± 4 (p < 0.05 vs. baseline), and 40 ± 4% (p < 0.05 vs. baseline), respectively. The effect of 17β-estradiol in hearts from male rats was similar but less pronounced compared with females [ΔCF 8 ± 3, 19 ± 3 (p < 0.05 vs. baseline)] and 25 ± 7% (p < 0.05 vs. baseline; p < 0.05 vs. female 17β-estradiol). Maximum vasodilation by the stereoisomer 17α-estradiol was significantly smaller [ΔCF 5 ± 3, 4 ± 3 (p < 0.05 vs. female 17β-estradiol) and 14 ± 1% (p < 0.05 vs. baseline; p < 0.05 vs. female 17β-estradiol)] for 10−6, 5 × 10−6, and 10−5M. Pretreatment with the NO-synthesis inhibitor Nω-methyl-L-arginine (10−4M) had no effect on the maximal vasodilator response to 17β-estradiol (10−5M) [ΔCF 36 ± 6% (p < 0.05 vs. baseline)]. When hearts were pretreated with the prostaglandin-synthesis inhibitor diclofenac (10−6M), the maximal vasodilator effect of 17β-estradiol was partially attenuated [ΔCF 12 ± 7% (p < 0.05 vs. female 17β-estradiol)]. Similarly, pretreatment with the K+ATP-blocker glibenclamide (10−6M) partially inhibited the maximal vasodilator effect of 17β-estradiol [ΔCF 22 ± 6% (p < 0.05 vs. baseline; p < 0.05 vs. female 17β-estradiol)]. Pretreatment with the Ca2+ channel antagonist nifedipine (7.2 × 10−8M) completely blocked the vasodilator effect. In isolated perfused rat hearts, 17β-estradiol induced marked acute coronary vasodilation; this effect is in part gender specific, and in female hearts, largely stereoisomer specific. The dilator effect is mediated predominantly by calcium channel blockade, but prostaglandin release and K+ATP channel activation also are involved. In the isolated perfused rat heart, NO production does not contribute to the acute vasodilator effect of 17β-estradiol.Keywords
This publication has 29 references indexed in Scilit:
- Effect of 17-β Estradiol in the Rabbit: Endothelium-Dependent and -Independent Mechanisms of Vascular RelaxationJournal of Cardiovascular Pharmacology, 1997
- Mechanisms of estrogen-induced vasodilation: In vivo studies in canine coronary conductance and resistance arteriesJournal of the American College of Cardiology, 1995
- 17-β-Estradiol Stimulation of Endothelial K+ ChannelsBiochemical and Biophysical Research Communications, 1995
- 17 beta-estradiol stimulates prostacyclin, but not endothelin-1, production in human vascular endothelial cellsJournal of Clinical Endocrinology & Metabolism, 1995
- Endothelium independent relaxation of human coronary arteries by 17 -oestradiol in vitroCardiovascular Research, 1993
- Regulation of Arterial Tone by Activation of Calcium-Dependent Potassium ChannelsScience, 1992
- Effects of endothelin-1 in the isolated heart in ischemia/reperfusion and hypoxia/reoxygenation injuryJournal of Molecular and Cellular Cardiology, 1991
- Gene regulation by steroid hormonesCell, 1989
- Role of 4-Hydroxylated Estradiol in Reducing Ca2+ Uptake of Uterine Arterial Smooth Muscle Cells through Potential-Sensitive Channels1Biology of Reproduction, 1987
- Stimulation of prostacyclin biosynthetic activity by estradiol in rat aortic smooth muscle cells in cultureBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980